Tolerance to vancomycin in pneumococci: Detection with a molecular marker and assessment of clinical impact

Journal of Infectious Diseases

Volumn 190, Issue 8, 2004, Pages 1481-1487

  Rodriguez, Carina A ^a   Atkinson, Robyn ^a   Bitar, Wally ^a   Whitney, Cynthia G ^c   Edwards, Kathryn M ^b   Mitchell, Lauren ^a   Li, Juan ^a   Sublett, Jack ^a   Li, Chin Shang ^a   Liu, Tiebin ^a   Chesney, F Joan ^a   Tuomanen, Elaine I ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMOXICILLIN; AUTOLYSIN; CEFOTAXIME; CEFTRIAXONE; CLAVULANIC ACID; COTRIMOXAZOLE; DNA; ERYTHROMYCIN; OXACILLIN; PENICILLIN DERIVATIVE; SULFONAMIDE; VANCOMYCIN;

ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; DNA SEQUENCE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; GENE SEQUENCE; HUMAN; MALE; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SURVIVAL;

ALLELES; ANTI-BACTERIAL AGENTS; CARRIER STATE; CHILD; DRUG RESISTANCE; FEMALE; GENES, BACTERIAL; GENETIC MARKERS; HUMANS; MALE; MENINGITIS; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; NASOPHARYNX; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN KINASES; STREPTOCOCCUS PNEUMONIAE; SURVIVAL ANALYSIS; VANCOMYCIN;

EID: 4944252172     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/424467     Document Type: Article

References (25)

1. Novak R, Henriques B, Charpentier E, Normark S, Tuomanen E. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999; 399:590-3.
2. Henriques Normark B, Novak R, Ortqvist A, Kallenius G, Tuomanen E, Normark S. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis 2001; 32:552-8.
3. Schuchat A, Hilger T, Zell E, et al. Active bacterial core surveillance of the Emerging Infections Program Network. Emerg Infect Dis 2001; 7:92-9.
4. Hoban D, Doern G, Fluit A, Foussel-Delvallez M, Jones R. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis 2001; 32: S81-93.
5. Whitney C, Parley M, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343:1917-24.
6. Tomasz A, Albino A, Zanati E. Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 1970; 227:138-40.
7. Handwerger S, Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis 1985; 7:368-86.
8. Tuomanen E, Durack DT, Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother 1986; 30:521-7.
9. Novak R, Charpentier E, Braun J, Tuomanen E. Signal transduction by a death signal peptide: uncovering the mechanism of bacterial killing by penicillin. Molec Cell 2000; 5:49-57.
10. Filipe S, Severina E, Tomasz A. The murMN operon: a functional link between antibiotic resistance and tolerance in Streptococcus pneumoniae. Proc Natl Acad Sci USA 2002; 99:1550-5.
11. Henriques Normark B, Normark S. Antibiotic tolerance in pneumococci. Clin Microbiol Infect 2002; 8:613-22.
12. Liu H, Tomasz A. Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. J Infect Dis 1985; 152:365-72.
13. McCullers J, English K, Novak R. Isolation and characterization of vancomycin tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis 2000; 181:369-73.
14. Edwards K, Wandlin G, Palmer P, Decker M. Carriage of pneumococci among infants immunized with a 9-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age [abstract 34]. In: Program and abstracts of the Congress of the Infectious Diseases Society of America (Philadelphia). Alexandria, VA: 1999:208.
15. Weiser J, Austrian R, Sreenivasan P, Masure H. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 1994; 62:2582-9.
16. Rudolph K, Crain M, Parkinson A, Roberts M. Characterization of a multidrug-resistant clone of invasive Streptococcus pneumoniae serotype 6B in Alaska using pulse-field gel electrophoresis and PspA serotyping. J Infect Dis 1999; 180:1577-83.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1990.
18. Zeger S, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42:121-30.
19. Peto R, Pike M, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35:1-39.
20. Dagan R, Leibovitz E, Cheletz G, et al. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J 1998; 17:880-5.
21. Robertson G, Zhao J, Desai B, et al. Vancomycin tolerance induced by erythromycin but not by loss of vncRS, vex3, or pep27 function in Streptococcus pneumoniae. J Bacteriol 2002; 184:6987-7000.
22. Diaz E, Lopez R, Farcia J. Role of the major pneumococcal autolysin in the atypical response of a clinical isolate of Streptococcus pneumoniae. J Bacteriol 1992; 174:5508-15.
23. Dowson C, Barcus B, King S, Pickerill P, Whatmore A, Yeo M. Horizontal gene transfer and the evolution of resistance and virulence determinants in Streptococcus. Soc Appl Bacteriol Symp Ser 1997; 26:42S-51S.
24. Sanchez-Puellas J, Garcia J, Lopez R, Garcia E. 3′-end modifications of the Streptococcus pneumoniae lytA gene: role of the carboxyterminus of the pneumococcal autolysin in the process of enzymatic activation. Gene 1987; 61:13-9.
25. Pikis A, Campos J, Rodriguez W, Keith J. Optochin resistance in Streptococcus pneumoniae: mechanism, significance, and clinical implications. J Infect Dis 2001; 184:582-90.